Microfluidic technologies have seen great advances over the past few decades in addressing applications such as biochemical analysis, pharmaceutical development, and point-of-care diagnostics. Miniaturization of biochemical operations performed on lab-on-a-chip microfluidic platforms benefit from reduced sample, reagent, and waste volumes, as well as increased parallelization and automation. This allows for more cost-effective operations along with higher throughput and sensitivity for faster and more efficient sample analysis and detection.